KALA BIO cuts Q3 net loss by 90% to $0.8 million

KALA BIO reported preliminary third-quarter 2026 financial results showing a functioning turnaround with a net loss of approximately $0.8 million. This represents a substantial 90% reduction versus the prior year and follows the closure of the Company's capital raise, positioning it for sustainable operations.